Compositions and methods of use of compounds to increase cancer patient survival time

Details for Australian Patent Application No. 2008352603 (hide)

Owner BioNumerik Pharmaceuticals, Inc.

Inventors Hausheer, Frederick H.

Agent Pizzeys

Pub. Number AU-B-2008352603

PCT Pub. Number WO2009/113989

Priority 12/075,980 14.03.08 US; PCT/ US2008/003405 14.03.08 US

Filing date 15 July 2008

Wipo publication date 17 September 2009

Acceptance publication date 31 May 2012

International Classifications

A61K 31/255 (2006.01)

Event Publications

30 September 2010 PCT application entered the National Phase

  PCT publication WO2009/113989 Priority application(s): WO2009/113989

31 May 2012 Application Accepted

  Published as AU-B-2008352603

27 September 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008352613-Flashback blood collection needle

2008352598-Chemoprotective methods and compositions